| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 4.82 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This Master's thesis presents a business plan developed as part of a group project, focusing on
the venture development of an innovative approach to reduce postoperative bleeding — a critical
healthcare challenge with substantial health, social, and economic implications. It proposes
preoperative supplementation with microencapsulated arachidonic acid (AA) based on recent
research that correlates higher levels of AA with a reduced risk of bleeding. Within the broader
scope of the group's thesis, this contribution explicitly addresses the scientific foundations and
the business concept of the proposed venture.
Descrição
Palavras-chave
Micro encapsulation Vascular surgery Biotechnology Biomedical innovation Venture development Molecular medicine Pharmaceutical sciences Hemostatic agents Market access Business strategy Competitive analysis Healthcare economics Regulatory strategy
